Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles

References

• Jemal A, Siegel R, Xu J, et al. Cancer statistics. CA Cancer J Clin. 2010;60:277–300.
   PubMed Web of Science ®Google Scholar
• Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189–207.
   PubMedGoogle Scholar
• Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci. 2002;99:1443–1448.
   PubMed Web of Science ®Google Scholar
• Han HD, Mangala LS, Lee JW, et al. Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clin Cancer Res. 2010;16:3910–3922.
   PubMed Web of Science ®Google Scholar
• Morrissey DV, Lockridge JA, Shaw L, et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotech. 2005;23:1002–1007.
   PubMed Web of Science ®Google Scholar
• Howard KA, Paludan SR, Behlke MA, et al. Chitosan/siRNA nanoparticle-mediated TNF-α knockdown in peritoneal macro- phages for anti-inflammatory treatment in a murine arthritis model. Mol Ther. 2009;17:162–168.
   PubMed Web of Science ®Google Scholar
• Dash M, Chiellini F, Ottenbrite RM, et al. Chitosan—A versatile semi-synthetic polymer in biomedical applications. Prog Pol Sci. 2011;36(8):981–1014.
   Web of Science ®Google Scholar
• Malmo J, Vårum KM, Strand SP. Effect of chitosan chain architecture on gene delivery: comparison of self-branched and linear chitosans. Biomacromolecules. 2011;12:721–729.
   PubMed Web of Science ®Google Scholar
• Strand SP, Issa MM, Christensen BE, et al. Tailoring of chitosans for gene delivery: novel self-branched glycosylated chitosan oligomers with improved functional properties. Biomacromolecules. 2008;9:3268–3276.
   PubMed Web of Science ®Google Scholar
• Germershaus O, Mao S, Sitterberg J, et al. Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro. J Cont Release. 2008;125:145–154.
   PubMed Web of Science ®Google Scholar
• Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol. 2010;56:290–299.
   PubMed Web of Science ®Google Scholar
• Strand SP, Tømmeraas K, Vårum KM, et al. Electrophoretic light scattering studies of chitosans with different degrees of N-acetylation. Biomacromolecules. 2001;2:1310–1314.
   PubMed Web of Science ®Google Scholar
• Liu X, Howard KA, Dong M, et al. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials. 2007;28:1280–1288.
   PubMed Web of Science ®Google Scholar
• Dehousse V, Garbacki N, Jaspart S, et al. Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro. Int J Biol Macromol. 2010;46:342–349.
   PubMed Web of Science ®Google Scholar
• Katas H, Oya AH. Develpment and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. 2006;115:216–225.
   PubMed Web of Science ®Google Scholar
• Doolittle H, Morel A, Talbot D. Survivin-directed anticancer thera- pies – A review of pre-clinical data and early-phase clinical trials. Eur Oncol. 2010;6:10–14.
   Google Scholar
• Park E, Gang EJ, Hsieh YT, et al. Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood. 2011;118:2191–2199.
   PubMed Web of Science ®Google Scholar
• Liu F, Xie ZH, Cai GP, et al. The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells. Biol Pharm Bull. 2007;30(12):2279–2283.
   PubMed Web of Science ®Google Scholar
• Unsoy G, Yalcin S, Khodadust R, et al. Synthesis optimization and characterization of chitosan-coated iron oxide nanoparticles produced for biomedical applications. J Nanoparticle Res. 2012;14(11):1–13.
   PubMed Web of Science ®Google Scholar
• Kars MD, Iseri ÖD, Gündüz U, et al. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds. Anticancer Res. 2006;26(6B):4559–4568.
   PubMed Web of Science ®Google Scholar
• Unsoy G, Khodadust R, Yalcin S, et al. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. Eur J Pharm Sci. 2014;62:243–250.
   PubMed Web of Science ®Google Scholar
• Unsoy G, Yalcin S, Khodadust R, et al. Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy. Biomed Pharmacother. 2014;68(5):641–648.
   PubMed Web of Science ®Google Scholar
• Pierog M, Gierszewska-Drużyńska M, Ostrowska-Czubenko J. Effect of ionic crosslinking agents on swelling behavior of chitosan hydrogel membranes. Progress on chemistry and application of chitin and its derivatives. Polish Chitin Soc Łódź. 2009;75:82.
   Google Scholar
• Van Woensel M, Wauthoz N, Rosière R, et al. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration. J Cont Release. 2016;227:71–81.
   PubMed Web of Science ®Google Scholar
• Lavertu M, Méthot S, Tran-Khanh N, et al. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials. 2006;27(27):4815–4824.
   PubMed Web of Science ®Google Scholar
• Aydin R, Pulat M. 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics. J Nanomaterials 2012;2012:42:1–10. doi:10.1155/2012/313961.
   Google Scholar
• Yuan Q, Shah J, Hein S, et al. Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. Acta Biomaterialia. 2010;6(3):1140–1148.
   PubMed Web of Science ®Google Scholar
• Huang Y, Cai Yuhang, Lapitsky Y. Factors affecting the stability of chitosan/ tripolyphosphate micro- and nanogels: resolving the opposing findings. J Mater Chemistry B. 2015;3:5957. dOI: 10.1039/c5tb00431d.
   Google Scholar
• Pillai CKS, Paul W, Sharma CP. Chitin and chitosan polymers: Chemistry, solubility and fiber formation. Prog Polym Sci. 2009;34:641–678.).
   Web of Science ®Google Scholar
• Raja MAG, Katas H, Wen TJ. Stability, intracellular delivery, and release of siRNA from chitosan nanoparticles using different cross-linkers. Plos One. 2015;10(6):e0128963.
   PubMed Web of Science ®Google Scholar
• Tsai ML, Chen RH, Bai SW, et al. The storage stability of chitosan/tripolyphosphate nanoparticles in a phosphate buffer. Carb Poly. 2011;84(2):756-761.).
   Web of Science ®Google Scholar
• Chou ST, Hom K, Zhang D, et al. Enhanced silencing and stabilization of siRNA polyplexes by histidine-mediated hydrogen bonds. Biomaterials. 2014;35(2):846–855.
   PubMed Web of Science ®Google Scholar
• Huang M, Ma Z, Khor E, et al. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res. 2002;19(10):1488–1494.
   PubMed Web of Science ®Google Scholar
• Nguyen J, Szoka FC. Nucleic acid delivery: the missing pieces of the puzzle? Acc Chem Res. 2012;45:1153–1162.
   PubMed Web of Science ®Google Scholar
• Ragelle H, Vandermeulen G, Préat V. Chitosan-based siRNA delivery systems. J Controlled Release. 2013;172(1):207–218.
   PubMed Web of Science ®Google Scholar
• Unsoy G, Gunduz U. Smart drug delivery systems in cancer therapy. Curr Drug Targets. 2016;17:1. doi:10.2174/138945011766616040112462.
   PubMedGoogle Scholar
• Wang T, Gantier MP, Xiang D, et al. Epcam aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model. Theranostics. 2015;5(12):1456.
   PubMed Web of Science ®Google Scholar